I. Introduction
The liver is the largest organ in the bodyand one of the most complex functioning organs with a wide array of functions.It plays a major role in carbohydrate, protein, lipid metabolism; inactivation of various toxins, metabolism of drugs, hormones, synthesis of plasma proteins & maintenance of immunity (Kupffer cells).Right from being a primary site of haematopoiesis in fetal life to maintenance of hematological parameters in postnatal life; the liver has an extremely important role in maintenance of blood homeostasis.It acts as a storage depot for Iron, Folic acid & Vitamin B12, secretes clotting factors and inhibitors. Hence it's not surprising to see a wide range of hematological abnormalities in liver diseases.In chronic liver disease the presence of jaundice, liver cell failure, portal hypertension and hypersplenism, reduced red cell half-life all influence peripheral blood picture. Both Liver cell failure & cholestasis can derange the coagulation system. Dietary deficiencies, bleeding, alcoholism and abnormalities in hepatic synthesis of proteins used for blood formation or coagulation add to the problem liver disease.This study was undertaken to describe the coagulation abnormalities in chronic liver disease so that measures could be taken to correct them and reduce morbidity.
Aim Of The Study
To assess the hematological profile of patients with chronic liver disease and their correlation in patients with GI bleed.
II. Materials And Methods
To assess the hematological abnormalities in chronic liver disease, a cross sectional analytical study was conducted All patients taken up for the study were evaluated in detail. Oral consent was obtained for clinical examination and lab investigations. Written consent was obtained for procedures such paracentesis, Upper GI endoscopy and viral marker studies.
Inclusion
Criteria  All patients with liver disease whose symptoms and signs persists for more than 6 months  Alcoholic cirrhosis, post-necrotic cirrhosis, metabolic causes of liver diseases were taken up for the study Exclusion Criteria  Patients with underlying malignancy or known primary hepatocellular carcinoma were excluded  Patients with primary coagulation disorder or primary abnormalities of haemostatic function were excluded.  Acute hepatic failure was excluded  Patients with preexisting anemia due to other causes were excluded.  Patients suffering from end stage medical diseases like COPD, Coronary artery disease, cardiac failure, CKD were excluded
III. Observation & Data Analysis
A descriptive study to assess the haematological abnormalities in chronic liver disease was conducted at Department of Digestive Health and diseases, Kilpauk medical college, Chennai from August 2016 to January 2017.
Age Distribut Ion Of Case S
The age range was from 24 to 70. The average age of the patients in the study was 48 yrs. 70 % of the patients were between 40 and 60 years of age DOI: 10.9790/0853-1606143844 www.iosrjournals.org 41 | Page
AetiologyOf Chronic Liver Disea Se
2% of the patients had alcoholic cirrhosis were males. Theaetiology of chronic liver disease could not be determined in 24 % of cases but all ofthem had clinical and radiological features of cirrhosis.6 patients had Hepatitis B and 2 had Hepatitis C; all these 8 patients had cirrhosis. Autoimmune hepatitis and cirrhosis were present in 2 females
Past History Of Jaundice
Of the 50 patients with Cirrhotic liver only 14 patients gave past history of jaundice. Serology proved that 4 patients had hepatitis B and 2 had hepatitis C. One female patient had recurrent history of jaundice and was diagnosed as a case of Wilsons disease.
Platelet AbnormalitIes
50 % of the patients had thrombocytopenia (<1 lakh)Of the 13 patients who had an upper GI bleed 3 patients had normal platelet counts and the rest had counts below 1 lakh. The average platelet count of patients who experienced an upper GI bleed was 92000 vs. 1.2 lakh in patients without a GI bleed.
Comp ArisonOf P Latelet Counts In P Atients Wi Th And Without Uppe R Gi Bleed
The bleeding time was prolonged only in 6 patients with thrombocytopenia indicating BT as an insensitive test. 
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IV. Discussion
This study conducted at Department of digestive health and diseases hospital, Kilpauk medical college involving 50 patients has thrown light on many of the hematological abnormalities that is seen in chronic liver disease. In our study, of the 13 patients who had an upper GI bleed, 3 patients had normal platelet counts and the rest had average platelet count of 92000. The bleeding time was prolonged only in 12% of patients with thrombocytopenia. This clearly indicates that bleeding time as an insensitive test for platelet function conforming to the result shared by Basili S et al; and functional abnormalities probably play a role. However due to lack of facilities platelet functional studies could not be taken up.
Platelet Abnormalities
Coagulation Abnormalities
A deranged coagulation system is very common in chronic liver disease. There is reduced synthesis of all coagulation factors (except factor VIII & Von Willi Brand factor), Vitamin K deficiency, Hyperfibrinolysis&dysfibrinogenemia, all contributing to increased bleeding tendency.Tripodi et al HEPATOLOGY 2005 through an elegant study have shown in addition to the diminished hepatic synthesis of clotting factors, patients also have a profound deficit of natural anticoagulants, mainly of protein C (a protein synthesized by the liver), and also of anti-thrombin, which may counterbalance the bleeding tendency caused by the deficiency in procoagulants. This was the concept of theRebalanced Haemostatic system, which can be tipped in favor of bleeding or thrombosis depending on the clinical situation.
In our particular study as much as 72% of patients had a prolonged PT-INR, though only 25 % of these patients had an upper GI bleed. This may suggest a rebalanced coagulation system in action to prevent bleed, however we did not have any patient with DCLD who presented with thrombosis. Individual assessment of procoagulants& endogenous anticoagulants were not possible due to lack of facilities and are definitely warranted for more conclusive results..Thus from this limited study of 50 patients with chronic liver disease we were able to draw many inferences regarding the haematological abnormalities that contribute to the morbidity of patients.Many of the results obtained conform to previously done studies mentioned earlier but whether these results can be extrapolated to the larger population of cirrhotic patients as a whole is not definitely known and needs larger, more comprehensive studies with a wider range of patient selection.
V. Conclusions
Many conclusive results regarding the haematological abnormalities in decompensated chronic liver disease were obtained with this limited study involving 50 patients with decompensated cirrhosis ⇒ 50 % of patients had thrombocytopenia. ⇒ The average platelet count of patients with an upper GI bleed was 92000 compared to 1.2 lakh to those without an upper GI bleed; suggesting other factors such functional platelet defects may play a role as well. These need to be confirmed with platelet functional studies. ⇒ Bleeding time was prolonged only in 12 % of patients with thrombocytopenia indicating BT as an insensitive test of platelet number and function. ⇒ The PT-INR was elevated in 72 % of patients. However only 25 % of patients with a prolonged PT-INR had upper GI bleed indicating other factors such as a rebalanced hemostatic system at work, however this needs to be confirmed with more extensive studies. This result underlines the fact that clinical status of the patient and not lab values have to be treated, when correcting coagulopathy in a patient with cirrhosis.
From this study we can conclude that various hematological alterations are very common in cirrhosis patients that needs to be identified and corrected early to reduce morbidity and mortality.
